Emcure Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹1,439.60(2.18%)December 12, 2025 15:57:15 PM IST
- NSE
- BSE
- Vol : 183.39 K (NSE + BSE)Last 20 day avg : 604.76 K
Emcure Pharmaceuticals is trading 2.18% upper at Rs 1,439.60 as compared to its last closing price. Emcure Pharmaceuticals has been trading in the price range of 1,465.50 & 1,406.60. There are 6 analysts who have initiated coverage on Emcure Pharmaceuticals. There are 5 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 243.46 Crores in its last quarter.Listed peers of Emcure Pharmaceuticals include Sun Pharmaceutical Industries (-0.69%), Torrent Pharmaceuticals (-0.56%), Divi's Laboratories (-0.27%).The Mutual Fund holding in Emcure Pharmaceuticals was at 3.58% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Emcure Pharmaceuticals was at 3.29% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 12, 2025, 10:57 PM UTC
- Debt To EquityHigher than industry0.23The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.21Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation25.51The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,794.50 | -0.69 | 4,30,478.68 | 37.94 | 6.04 | 0.88 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 3,780.00 | -0.56 | 1,27,870.05 | 66.64 | 16.92 | 0.84 | 17.62 |
| Divi's Laboratories | Bullish | 6,414.50 | -0.27 | 1,70,282.17 | 78.27 | 11.47 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bullish | 1,279.50 | 0.51 | 1,06,784.78 | 18.80 | 3.17 | 0.63 | 2.34 |
| Cipla | Neutral | 1,515.15 | 0.20 | 1,22,397.55 | 23.33 | 3.94 | 0.85 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE168P01015
- BSE Code544210
- NSE CodeEMCURE
Emcure Pharmaceuticals is trading at 1439.60 as on Fri Dec 12 2025 10:27:15. This is 2.18% upper as compared to its previous closing price of 1408.90.
The market capitalization of Emcure Pharmaceuticals is 27404.51 Cr as on Fri Dec 12 2025 10:27:15.
The average broker rating on Emcure Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Emcure Pharmaceuticals is 1524.85 whereas the 52 wk low is 890.00
Emcure Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: -
- Dividend Yield: %
- D/E ratio: -
Emcure Pharmaceuticals reported a net profit of 681.33 Cr in 2025.
The Mutual Fund Shareholding was 3.58% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Emcure Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.